SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 25 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $291,564 | +4.5% | 150,000 | 0.0% | 0.00% | – |
| Q4 2022 | $279,047 | +10.7% | 150,000 | 0.0% | 0.00% | – |
| Q3 2022 | $252,000 | -93.9% | 150,000 | -95.4% | 0.00% | -100.0% |
| Q2 2022 | $4,108,000 | -37.1% | 3,250,000 | -35.0% | 0.01% | -30.0% |
| Q1 2022 | $6,535,000 | +62.1% | 5,000,000 | +81.8% | 0.01% | +66.7% |
| Q4 2021 | $4,031,000 | -50.3% | 2,750,000 | -50.0% | 0.01% | -53.8% |
| Q3 2021 | $8,116,000 | +206.6% | 5,500,000 | +175.0% | 0.01% | +225.0% |
| Q2 2021 | $2,647,000 | +1.3% | 2,000,000 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $2,613,000 | +325.6% | 2,000,000 | +700.0% | 0.01% | +400.0% |
| Q4 2020 | $614,000 | -60.4% | 250,000 | -66.7% | 0.00% | -75.0% |
| Q3 2020 | $1,551,000 | +169.3% | 750,000 | +200.0% | 0.00% | +100.0% |
| Q2 2020 | $576,000 | -23.7% | 250,000 | -50.0% | 0.00% | -33.3% |
| Q1 2020 | $755,000 | -61.7% | 500,000 | -66.7% | 0.00% | -50.0% |
| Q3 2019 | $1,972,000 | – | 1,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 27,809,000 | $68,028,000 | 7.58% |
| DeepCurrents Investment Group LLC | 59,662,000 | $145,743,000 | 3.83% |
| WOLVERINE ASSET MANAGEMENT LLC | 87,665,000 | $214,228,000 | 1.57% |
| CSS LLC/IL | 13,674,000 | $33,505,000 | 1.28% |
| SSI INVESTMENT MANAGEMENT LLC | 6,412,000 | $15,722,000 | 1.12% |
| WHITEBOX ADVISORS LLC | 12,172,000 | $29,843,000 | 0.94% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 13,307,000 | $32,575,000 | 0.69% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5,000,000 | $12,208,000 | 0.47% |
| AQR Arbitrage LLC | 4,625,000 | $11,351,000 | 0.40% |
| Calamos Advisors LLC | 25,131,000 | $61,472,000 | 0.36% |